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General information General methods
NMR spectra were recorded on a liquid NMR spectrometer (400 MHz for 1 H and 100 MHz for 13 C) using CDCl 3 as the solvent. The residual proton in CDCl 3 (δ= 7.27) served as an internal standard for 1 H NMR, and the 13 C-atom of CDCl 3 was used as an internal standard (δ= 77 for 13 C NMR. Chemical shifts are reported in ppm and the coupling constants J are given in Hz. The following abbreviations were used to explain the multiplicities: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet). Infrared spectra were recorded on an FT-IR spectrometer, and only major peaks were reported in cm -1 . HRMS data were obtained by the ESI ionization sources.
Purification of the products was performed by column chromatography on silica gel (200-300 mesh).
Materials
Catalysts and 3,5-dimethyl-4-nitroisoxazole are commercially available. 3,5-diethyl-4-nitroisoxazole was prepared according to the literature procedures.
1
The 2-Aryl-1,2,3,4-tetrahydro-isoquinolines were prepared according to the literature method.
2 Unless otherwise noted, analytical grade solvents and commercially available reagents were used without further purification. The mixture of 4-nitroisoxazoles 2 (0.2 mmol), N-Aryl-1,2,3,4-tetrahydro-isoquinolines 1 (0.4 mmol) and CuBr (10 mol%, 0.02 mmol) in 0.4 mL H 2 O were stirred at 50℃ or 80℃ for the indicated time. After the reaction was completed, the mixture was extracted with ethyl acetate. The combined organic phase was dried over Na 2 SO 4 and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, petroleumether/ethyl acetate = 50:1~10:1) to give the desired products 3. It should be noted that products 3 were found to be a slightly unstable to column chromatographic purification. 
3-methyl-4-nitro-5-((
Synthesis of compound 6:
3a (0.16 mmol) and NaOH (0.16 mmol) were disolved in 0.1 mL hydrazine hydrate. The resulted mixture was stirred at 60℃ for 8 h. It was then transferred into a large beaker, diluted with water and cooled with an ice-bath. The pH was adjusted to 7.0 by addition of 3N HCl, and then extracted with ethyl acetate (5×2 mL). The combined organic phase was dried over Na 2 SO 4 and concentrated in vacuo. The residue was puried by column chromatography (silica gel, petroleumether/ethyl acetate = 2:1) to give a white solid of 1-((3-methyl-4-nitro-1H-pyrazol-5-yl)methyl)-2-phenyl-1,2,3,4-tetrahydroisoquin oline (6) 3a (0.25 mmol) was disolved in THF (1 mL) and MeOH (1 mL), the resulted mixture was cooled to 0 ℃ and treated with a solution of NaBH 4 (28.5 mg, 0.75 mmol) in MeOH (0.5 mL). The solution of the reducent was added drop wise in a 5 minutes period. The reaction mixture was then stirred for additional 60 minutes, then quenched with water (3 mL). The pH was adjusted to 7.0 by addition of 3N HCl, and then extract with ethyl acetate (5×2 mL). The combined organic phase was dried over Na 2 SO 4 and concentrated in vacuo. The residue was puried by column chromatography (silica gel, petroleumether/ethyl acetate = 10:1) to give compound 3-methyl-4-nitro-5-((2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-4,5-dih ydroisoxazole (7) 149.0, 134.9, 129.5, 129.4, 129.3, 127.0, 126.8, 126.3, 119.4, 116.2, 97.0, 82.4, 56.3, 40.4, 35.1, 25.0, 11.6 
